SHL Medical and Kindeva partner to enhance services for Molly® autoinjector platform

SHL Medical, a world-leading solutions provider of advanced drug delivery systems, and Kindeva Drug Delivery, a global CDMO and drug delivery expert, are partnering to offer fill finish and pre-validated final assembly services for SHL Medical’s Molly® autoinjector platform at Kindeva’s Bridgeton and Maryland Heights facilities.

Built on a modular platform technology, Molly® is a single-dose autoinjector developed to help pharma and biotech companies reduce initial investments and expedite development timelines.

This strategic partnership between SHL and Kindeva will enhance collaboration, resulting in faster project completion,  streamlined communication, and efficient delivery of drug products.

Being one of only a few CDMOs who can address a full end-to-end range of services in one geographic location, Kindeva contributes to simplified supply chains.

Markus Puusepp, SHL Medical’s Chief Growth Officer, commented on the collaboration: “We are excited to partner with Kindeva to further enhance the capabilities of our Molly® autoinjector platform. This partnership will allow us to provide our customers with more efficient and comprehensive solutions, ultimately accelerating the delivery of innovative therapies to patients worldwide.”

Milton Boyer, CEO of Kindeva, said of the partnership: “Our collaboration with SHL Medical ensures that more patients will have access to treatments for a variety of conditions. By offering an integrated solution at our Bridgeton & Maryland Heights facilities, we can streamline project timelines, ensuring the timely, efficient, and safe delivery of drug products. I’m proud that our partnerships continue to have a positive impact on patients’ lives around the globe.”

About SHL Medical   

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by its company purpose – Enabling Patients’ Independence – SHL Medical offers patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. It also offers final assembly, labeling, and packaging solutions for its drug delivery systems.  ​  

In response to the rising trend in home therapy, SHL Medical has increased its developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. ​  

Located across Switzerland, Taiwan, Sweden, and the US, SHL Medical’s global team of experts collaborate seamlessly as one team in utilizing its comprehensive in-house manufacturing capabilities. Its solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into its designs and processes to contribute to a cleaner earth.  

​For additional information, visit www.shl-medical.com

Media contact: [email protected] 

About Kindeva

At Kindeva, our purpose is clear: manufacturing more tomorrows for patients worldwide. By investing in the highest quality facilities, finished-dose CDMO solutions and analytical capabilities, we provide strategic value that extends beyond manufacturing. Our global network of 10 manufacturing and R&D facilities offers exceptional capabilities, including expanded aseptic fill finish capacity and next-generation green propellant technologies. We leverage our sterile injectable, pulmonary, nasal and dermal expertise to help meet the demands of today and deliver the possibilities of tomorrow.

For additional information, visit kindevadd.com

Media contact:  [email protected]